`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ENZYMOTEC LTD.,
`Petitioner
`
`v.
`
`NEPTUNE TECHNOLOGIES AND BIORESSOURCES INC.,
`Patent Owner
`
`IPR2014-00556
`
`ENZYMOTEC LTD.’S UPDATED EXHIBIT LIST
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`1001
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`U.S. Pat. No. 8,278,351 to Sampalis (“’351”)
`
`WO 00/23546 to Beaudoin (“Beaudoin I”)
`
`Canadian Application 2,251,265 to Beaudoin (“Beaudoin II”)
`
`Certified translation of Ex. 1070: Japanese Unexamined Patent
`
`Application Publication No. 02-215351, titled Krill
`
`Phospholipids Fractioning Method (“Maruyama,”); Certificate
`
`of Translation provided as Ex. 1071.
`
`Certified translation of Ex. 1072: Fisheries Agency, General
`
`Report on Research and Development of Techniques in
`
`Processing and Utilization of Marine Products, Chapter 6,
`
`Development of technology for recovery of valuable substances
`
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March
`
`1985) (“Fujita”) ; Certificate of Translation provided as Ex. 1073.
`
`Fricke et al., Lipid, Sterol, and Fatty Acid Composition of
`
`Antarctic Krill, Lipids, Vol. 19, No. 11, pp. 821-827 (1984)
`
`
`
`
`
`
`
`
`
`
`(“Fricke”)
`
`1
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Bottino, N.R., “Lipid Composition of Two Species of
`
`Antarctic Krill: Euphausia Superba and E. Crystallorophias,”
`
`Comp. Biochem. Physiol., 1975, Vol. 50B, pp. 479-484
`
`(“Bottino”)
`
`Canadian Patent No. 1098900, titled Method for the Processing
`
`of Krill to Produce Protein, Lipids and Chitin (“Rogozhin”)
`
`Itano Refrigerated Food Co., Ltd., Bio & High Technology
`
`Announcement and Natural Astaxanthin & Krill Lecithin, pp. 1-
`
`16 (on or before December 28, 1994) (“Itano”)
`
`WO97/39759 to Stoll (“Stoll”)
`
`Final Prospectus dated May 11, 2001 (“Final Prospectus”)
`
`“Neptune Technologies & Bioressources Soon to Obtain a Major
`
`Patent in Over 30 Countries” (“2011 Press Release,”)
`
`Le Grandois et al., Investigation of Natural Phosphatidycholine
`
`Sources: Separation and Identification by Liquid
`
`1013
`
`Chromatography -Electrospray Ionization-Tandem Mass
`
`Spectrometry (LC-ESI- MS2) of Molecular Species, J. Agric.
`
`Food Chem., 57, 6014-20 (2009) (“Le Grandois”)
`
`2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Certified translation of Ex. 1074: Japanese Patent No. 60-
`
`153779, entitled “Nutritional Supplement” (“Fukuoka ”);
`
`Certificate of Translation provided as Ex. 1075
`
`Certified translation of Ex. 1076: Japanese Patent Publication
`
`No. H08-231391, entitled “Medicine for Improvement of
`
`Dementia Symptoms” (“Yasawa”); Certificate of Translation
`
`provided as Ex. 1077.
`
`Suzuki, T. and Shibata, N., “The utilization of Antarctic krill
`
`for human food,” Food Rev. Int’l, 6:1, 119-147 (1990)
`
`(“Suzuki”)
`
`Bergelson (ed.), Lipid Biochemical Preparations, Chapter I.1, pp.
`
`1-13 (1980) (“Bergelson”)
`
`WHO News and Activities, Bulletin of the World Health
`
`Organization, 73(4), pp. 547-51 (1995) (“WHO Bulletin”)
`
`Bell and Dick, Molecular Species Composition of the Major
`
`Diacyl Glycerophospholipids from Muscle, Liver, Retina and
`
`Brain of Cod (Gadus morhua), Lipids, Vol. 26, No. 8, pp. 565-
`
`573 (1991) (“Bell and Dick”)
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Henderson et al., Lipid Composition of the Pineal Organ from
`
`Rainbow Trout (Oncorhynchus mykiss), Lipids, Vol. 29, No.
`
`5, pp. 311-317 (1994) (“Henderson ”)
`
`Bell, Molecular Species Analysis of Phosphoglycerides from the
`
`Ripe Roes of Cod, Lipids, Vol. 24, No. 7 (1989)
`
`Takahashi et al., Compositional Changes in Molecular Species of
`
`Fish Muscle Phosphatidylcholine During Storage, Bull. Fac. Fish.
`
`Hokkaido Univ. 37(1), 80-84 1986.
`
`Takahashi et al., Prediction of Relative Retention Value of the
`
`Individual Molecular Species of Diacyl Glycerolipid on High
`
`Performance Liquid Chromatography, Bull. Fac. Fish.
`
`Hokkaido Univ. 38(4), 398-404. 1987
`
`Lin et al., Effect of Dietary N-3 Fatty Acids Upon the
`
`Phospholipid Molecular Species of the Monkey Retina,
`
`Invest Ophthalmol Vis Sci. 1994;35:794-803
`
`Farkas, Composition and Physical State of Phospholipids in
`
`Calanoid Copepods from India and Norway, LIPIDS, Vol. 23,
`
`No. 6 (1988)
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Bell, Molecular Species Composition of Phosphatidylcholine
`
`from Crypthecodinium cohnii in Relation to Growth Temperature
`
`Lipids 25, 115-118 (1990)
`
`Buda, Structural order of membranes and composition of
`
`phospholipids in fish brain cells during thermal
`
`acclimatization, Proc. Natl. Acad. Sci. USA Vol. 91, pp. 8234-
`
`8238, August 1994
`
`Takahashi et al., Molecular Species of Fish Muscle Lecithin,
`
`Bulletin of the Japanese Society of Scientific Fisheries
`
`48(12), 1803-1814 (1982)
`
`Tocher, Chapter 6, Glycerophospholipid metabolism,
`
`Biochemistry and molecular biology of fishes, vol. 4,
`
`Hochachka and Mommsen (eds.)(1995)
`
`Tanaka, Biosynthesis of 1,2-dieicosapentaenoyl-sn-glycero-3-
`
`phosphocholine in Caenorhabditis elegans, Eur. J. Biochem.
`
`263, 189±194 (1999)
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Winther et al., Elucidation of Phosphatidylcholine Composition
`
`in Krill Oil Extracted from Euphausia superba, Lipids 46(1):25-
`
`36 (2011)(“Winther”)
`
`Eichberg, “Lecithin – It Manufacture and Use in the Fat and Oil
`
`Industry,” Oils and Soap 51-54, 1939 (“Eichberg”)
`
`Balassa et al., Microencapsulation in the Food Industry, Critical
`
`Reviews in Food Technology, 2:2, 245-265 (1971)(“Balassa”)
`
`Buchi R-220 Rotovapor® Manual
`
`Johnson and Lucas, Comparison of Alternative Solvents for Oils
`
`Extraction, JAOCS 60(2):229-242 (1983)
`
`U.S. Pat. No. 4,714,571
`
`Grit et al., Int. J. Pharmaceutics 50:1-6 (1989)
`
`Herman and Groves, Pharmaceutical Research 10(5):774-
`
`776 (1993)
`
`Watanabe et al., Effective Components in Cuttlefish Meal
`
`and Raw Krill for Improvement of Quality of Red Seabream
`
`Pagrus major Eggs, Nippon Suisan Gakkaishi 57(4):681-694
`
`(1991)(“Watanabe”)
`
`6
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1040
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`1046
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Declaration of Dr. Richard van Breemen in Support of Inter
`
`Partes Review of U.S. Pat. No. 8,278,351 (“Van Breemen”)
`
`Declaration of Dr. Suzanne Budge in Support of Inter Partes
`
`Review of U.S. Pat. No. 8,278,351 (“Budge”)
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes
`
`Review of U.S. Pat. No. 8,278,351
`
`Expert Witness Report of Dr. Theodore Welch submitted
`
`in relation to ITC Investigation No. 337-TA-877
`
`(“Welch”)
`
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review
`
`of U.S. Pat. No. 8,278,351 (“Moore”)
`
`Declaration of Dr. Albert Lee in Support of Inter Partes Review
`
`of U.S. Pat. No. 8,278,351 (“Lee”)
`
`Declaration of Dr. Ivar Storrø in support of Inter Partes Review
`
`of U.S. Pat. No. 8,278,351 (“Storrø”)
`
`7
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Declaration of Bjorn Ole Haugsgjerd submitted during inter
`
`partes reexamination of parent patent U.S. 8,030,348
`
`(“Haugsgjerd ‘348
`
`Decl.”)
`
`Supplemental Declaration of Bjorn Ole Haugsgjerd submitted
`
`during inter partes reexamination of parent patent U.S.
`
`8,030,348 (“Haugsgjerd ‘348 Supp. Decl.”)
`
`Declaration of Dr. Thomas Gundersen submitted during inter
`
`partes reexamination of parent patent U.S. 8,030,348
`
`(“Gundersen Decl.”)
`
`Supplemental Declaration of Dr. Thomas Gundersen submitted
`
`during inter partes reexamination of parent patent U.S.
`
`8,030,348 (“Gundersen Supp. Decl.”)
`
`Declaration of Dr. Earl White submitted during prosecution
`
`of parent patent U.S. 8,030,348 (“2011 White Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`
`prosecution of parent patent U.S. 8,278,351 (“White Supp.
`
`Decl.”)
`
`8
`
`
`ENZYMOTEC
`EXHIBIT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`1058
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Declaration of Dr. Jacek Jaczynski from inter partes
`
`reexamination of the parent patent U.S. 8,030,348 (“Jaczynski
`
`Reexam. Decl.”)
`
`Declaration of Dr. Yeboah submitted during inter partes
`
`reexamination of parent patent U.S. 8,030,348 (“Yeboah
`
`Reexam Decl.”)
`
`Supplemental Declaration of Dr. Earl White submitted during
`
`inter partes reexamination of parent patent U.S. 8,030,348
`
`(“White
`
`Supp. Reexam. Decl.”)
`
`Declaration of Dr. Shahidi submitted during inter partes
`
`reexamination of parent patent U.S. 8,030,348 (Shahidi
`
`Reexam. Decl.”
`
`Declaration of Dr. Tina Sampalis submitted during inter
`
`partes reexamination of parent patent U.S. 8,030,348
`
`(Sampalis”)
`
`Declaration of Dr. Yeboah submitted during prosecution of
`
`parent patent U.S. 8,278,351 (“Yeboah ‘351 Decl.”)
`
`9
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Declaration of Dr. Shahidi submitted during prosecution of
`
`parent patent U.S. 8,278,351 (Shahidi ‘351 Decl.”)
`
`Declaration of Dr. Jaczynski submitted during prosecution
`
`of parent patent U.S. 8,278,351 (Jaczynski ‘351 Decl.”)
`
`April 2, 2012 Response to Office Action, ‘351 patent
`
`Provisional Application No. 60/307,842 (Priority document for
`
`the ‘351 patent)
`
`Office Action dated January 5, 2012, ‘351 patent
`
`Action Closing Prosecution, ‘348 patent
`
`Grant of Request for Ex parte Reexamination of the ‘351 patent
`
`Declaration of Dr. Van Breemen submitted during Ex parte
`
`Reexamination of the ‘351 patent (Van Breemen ‘351
`
`Reexam. Decl.”
`
`Declaration of Dr. Van Breemen submitted during Inter
`
`partes Reexamination of the ‘348 patent (Van Breemen ‘348
`
`Reexam Decl.”
`
`Medina et al., J. Amer. Oil Chem. Soc. 71(5):479-82 (1994)
`
`U.S. Patent No. 8,030,348
`
`
`ENZYMOTEC
`EXHIBIT
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1059
`
`1060
`
`1061
`
`1062
`
`1063
`
`1064
`
`1065
`
`1066
`
`1067
`
`1068
`
`1069
`
`10
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1070
`
`1071
`
`1072
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Japanese Unexamined Patent Application Publication No. 02-
`
`215351, titled Krill Phospholipids Fractioning Method; Japanese
`
`language document
`
`Certification of translation of Ex. 1070: Japanese Unexamined
`
`Patent Application Publication No. 02-215351
`
`Fisheries Agency, General Report on Research and
`
`Development of Techniques in Processing and Utilization of
`
`Marine Products, Chapter 6, Development of technology for
`
`recovery of valuable substances (astaxanthin) from krill, by
`
`Takao Fujita, pp. 273-307 (March 1985); Japanese language
`
`document
`
`Certificate of translation of Ex. 1072: Fisheries Agency, General
`
`Report on Research and Development of Techniques in
`
`Processing and Utilization of Marine Products, Chapter 6,
`
`1073
`
`Development of technology for recovery of valuable substances
`
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March
`
`1985); Japanese language document
`
`11
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ENZYMOTEC
`EXHIBIT
`
`1074
`
`1075
`
`1076
`
`1077
`
`1078
`
`1079
`
`1080
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`DESCRIPTION
`Japanese Patent No. 60-153779, entitled “Nutritional
`
`Supplement”; Japanese language document
`
`Certificate of translation of Ex. 1074: Japanese Patent No. 60-
`
`153779, entitled “Nutritional Supplement”
`
`Japanese Patent Publication No. H08-231391, entitled
`
`“Medicine for Improvement of Dementia Symptoms”; Japanese
`
`language document
`
`Certificate of translation of Ex. 1076: Japanese Patent
`
`Publication No. H08-231391, entitled “Medicine for
`
`Improvement of Dementia Symptoms”
`
`Folch, et al., A Simple Method for the Isolation and Purification
`
`of Total Lipids from Animal Tissues. J. Biol. Chem., 226, 497-
`
`509 (1957)
`
`Declaration of Dr. Chong Lee submitted during inter partes
`
`reexamination of parent patent U.S. 8,030,348 (“Yeboah
`
`Reexam Decl.”)
`
`Declaration of Bjorn Ole Haugsgjerd in support of Inter Partes
`
`Review of U.S. Pat. No. 8,278,351 (“Haugsgjerd”)
`
`12
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2014-00556
`Enzymotec Ltd.’s Updated Exhibit List
`
`
`ENZYMOTEC
`EXHIBIT
`
`DESCRIPTION
`Declaration of Daniel P. Margolis in Support of Motion for Pro
`
`1081
`
`Hac Vice Admission Under 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: May 30, 2014
`
`
`
`
`Respectfully submitted,
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Cynthia Lambert Hardman (Reg. No. 53,179)
`KENYON & KENYON LLP
`One Broadway
`New York, NY 10004-1007
`Tel: (212) 425-7200
`Fax: (212) 425-5288
`
`
`Counsel for Petitioner Enzymotec Ltd.
`
`
`
`13
`
`